1784 results for Treatments
Refine Your Search
Walgreens helps raise more than $6 million for The Leukemia & Lymphoma Society (LLS) and Susan G. Komen to Advance Cancer Research and Increase Access to Care
Join us in thanking Walgreens stores and customers across the country for raising over $6 million for LLS and Susan G. Komen during their spring campa…
Suggested Reading - 100 Questions & Answers About Cancer Symptoms and Cancer Treatment Side Effects
100 Questions & Answers About Cancer Symptoms and Cancer Treatment Side Effects By Joanne Frankel Kelvin, RN, MSN, AOCN & Leslie B. Tyson, MS, APN-BC,…
LLS advocates helped North Carolina expand Medicaid
North Carolina Gov. Roy Cooper just signed Medicaid expansion into law, following years of advocacy from LLS volunteers and staff. Once it takes effec…
Detection and treatment of Adult T cell leukemia/lymphoma in the premalignant stage.
Clonally expanded T cells carrying somatic mutations circulate in the premalignant phase of Adult T cell leukemia/lymphoma (ATL). We will develop capt…
Niclosamide for the Treatment of Relapsed/Refractory Pediatric Acute Myeloid Leukemia
Niclosamide is an FDA approved anti-parasitic drug that is well tolerated and acts synergistically with chemotherapy to kill AML cells. We will conduc…
Long-term and late effects of cancer treatment in children and teens
Support Resources
Latest FDA Approval Joins a Torrent of New Treatments for Aggressive Lymphoma Subtype
Rye Brook, N.Y., July 10, 2023 – The U.S. Food and Drug Administration (FDA) recently approved glofitamab-gxbm (Columvi™) to treat adults with diffuse…
News Release
Suggested Reading - Coping with the Emotional Impact of Cancer: Become an Active Patient and Take Charge of Your Treatment
Coping with the Emotional Impact of Cancer: Become an Active Patient and Take Charge of Your Treatment By Neil Fiore Bay Tree Publishing, 2009, 178 P…
Beyond Blankets: Subaru Loves to Care brings comfort and warmth
Blood cancer treatment can be a scary and confusing time. And blood cancer patients want to feel like they’re not alone. That’s why The Leukemia & Lym…
Holding onto hope: Living with chronic lymphocytic leukemia
Table of contents:Living with CLL: symptoms, treatment, & supportWhat is CLLCLL stagesCLL symptomsCLL testing and diagnosisCLL treatmentPrognosi…
European Commission Approves ELZONRIS for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
FLORENCE, January 21, 2021 – The Menarini Group, a privately held Italian pharmaceutical and diagnostics company, announced today that the European Co…
Clinical Trials: Why They Matter and How to Make Them More Accessible
Cancer treatments can be lifesaving. As an organization, The Leukemia & Lymphoma Society (LLS) has invested more than $1.7 billion in blood cancer res…
FDA Approves New Targeted Treatment Option for Certain Forms of Acute Myeloid Leukemia in Adults
The U.S. Food and Drug Administration (FDA) granted approval yesterday to olutasidenib (Rezlidhia™) for the treatment of adults with acute myeloid leu…
News Release
Blood Cancer 101: The Basics on Disease, Treatment, and the Role of the HCP
This activity is intended for oncology social workers, psychologists, nurses, and other healthcare professionals involved in the care of patients with…
Other
Treatment Advancements for Acute Lymphoblastic Leukemia (ALL) in Children and Adults
Topics Covered We invite you to learn more about: Treatment options for acute lymphoblastic leukemia (ALL) in children ALL treatment advances for…
Global Partnership to Fund Groundbreaking Research in Treatment of Multiple Myeloma
Groundbreaking research aimed at translating novel chimeric antigen receptor (CAR) T-cell therapies into improved treatment for multiple myeloma is th…
News Release
FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia
Asciminib provides another option to help CML patients live longer, healthier lives Rye Brook, N.Y., December 6, 2024 – The U.S. Food and Drug Adminis…
News Release